ABSIEVE

Owners

Goods & Services

Scientific and technological services and research projects for the preparation of peptide and antibody libraries, and for identification and characterization of binding molecules, namely, scientific research and analysis in the field of antibody discovery; scientific and technological services and research projects for the preparation, identification and characterisation of peptides and antibodies, namely, scientific research and analysis in the field of antibody discovery; scientific and technological services and research projects for the preparation and identification of recombinant antibodies, single-chain antibodies, diabodies, tandabs, flexibodies, triabodies, tetrabodies, bivalent antibodies, multivalent antibodies, whole immunoglobulins, and antibody fragments, in particular Fab and scFv fragments, and of nucleic acid sequences coding for these molecules, namely, scientific research and analysis in the field of antibody discovery; scientific and technological services and research projects in relation to antibody discovery, namely, scientific research and analysis in the field of antibody research and drug design; scientific and technological services and research projects in relation to screening of natural, engineered and immunized libraries, namely, scientific research and analysis in the field of antibody discovery; scientific and technological services and research projects in relation to screening of antibody libraries, namely, scientific research and analysis in the field of antibody discovery; scientific and technological services and research projects in relation to phage display, phage panning and yeast display vectors, namely, scientific research and analysis in the field of antibody discovery; scientific and technological services and research projects in relation to next-generation yeast display and antibody selection process, namely, scientific research and analysis in the field of antibody discovery; scientific and technological services and research projects in relation to the upstream enrichment of target-specific candidates and batch cloning into yeast-display vectors, namely, scientific research and analysis in the field of antibody discovery; scientific and technological services in relation to drug discovery by high throughput screen and antibody delivery for therapeutic application, namely, scientific research and analysis in the field of antibody research and drug design